We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

33 hedge funds and large institutions have $44.1M invested in HOOKIPA Pharma in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.03% more ownership

Funds ownership: 0% → 3.03% (+3%)

Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$20.1M
2
AG
Artal Group
Luxembourg
+$12M
3
BBA
Baker Bros. Advisors
New York
+$9.47M
4
HIM
Hillhouse Investment Management
Cayman Islands
+$6.98M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.35M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
$12.7M +$20.1M +189,188 New
AG
2
Artal Group
Luxembourg
$7.64M +$12M +113,462 New
BBA
3
Baker Bros. Advisors
New York
$6.01M +$9.47M +89,286 New
HIM
4
Hillhouse Investment Management
Cayman Islands
$4.42M +$6.98M +65,754 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$4.03M +$6.35M +59,850 New
SB
6
Samsara BioCapital
California
$3.57M +$5.62M +53,025 New
HA
7
HHLR Advisors
Cayman Islands
$1.92M +$3.03M +28,571 New
Artisan Partners
8
Artisan Partners
Wisconsin
$850K +$1.34M +12,627 New
BlackRock
9
BlackRock
New York
$737K +$1.16M +10,953 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$538K +$848K +7,992 New
Millennium Management
11
Millennium Management
New York
$328K +$517K +4,875 New
DIM
12
DC Investments Management
Virginia
$288K +$455K +4,286 New
Goldman Sachs
13
Goldman Sachs
New York
$254K +$400K +3,771 New
State Street
14
State Street
Massachusetts
$134K +$260K +2,454 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$116K +$184K +1,730 New
New York State Common Retirement Fund
16
New York State Common Retirement Fund
New York
$104K +$163K +1,540 New
Morgan Stanley
17
Morgan Stanley
New York
$99K +$157K +1,479 New
Northern Trust
18
Northern Trust
Illinois
$72K +$113K +1,064 New
Bank of America
19
Bank of America
North Carolina
$62K +$98.3K +927 New
TRCT
20
Tower Research Capital (TRC)
New York
$40K +$63.8K +601 New
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$24K +$38.2K +360 New
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$22K +$34.2K +322 New
Barclays
23
Barclays
United Kingdom
$22K +$34.4K +324 New
UBS Group
24
UBS Group
Switzerland
$13K +$20.9K +197 New
AIG
25
American International Group
New York
$9K +$14.1K +133 New
1
2

HOOK Hedge Fund Activity: Q2 2019 in Review

33 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2019, worth a combined $44.1M.

Buyers outnumbered sellers: 33 funds opened new HOOK positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $20.1M.

  • 33 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $44.1M of HOOKIPA Pharma stock for Q2 2019.
  • 33 funds opened new HOOKIPA Pharma positions in Q2 2019 and 0 closed out, a net change of +33 holders.
  • The largest HOOKIPA Pharma buyer in Q2 2019 was Redmile Group, an estimated $20.1M added.

Based on aggregated 13F filings for Q2 2019.